Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $7.6200 (-8.63%) ($7.6200 - $7.6200) on Mon. Mar. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.68% (three month average) | RSI | 18 | Latest Price | $7.6200(-8.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -5.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -18.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(72%) XBI(72%) ARKK(68%) IWO(66%) IBB(64%) | Factors Impacting CGEN price | CGEN will decline at least -2.34% in a week (0% probabilities). VIXM(-45%) VXX(-40%) UUP(-22%) IGOV(-7%) TLT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.34% (StdDev 4.68%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-21.91(-387.53%) | Inflection Point | Yes | Resistance Level | $10.94 | 5 Day Moving Average | $8.48(-10.14%) | 10 Day Moving Average | $9.08(-16.08%) | 20 Day Moving Average | $10.94(-30.35%) | To recent high | -46.4% | To recent low | 0% | Market Cap | $630m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |